A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease
Authors
Keywords
-
Journal
Journal of Crohns & Colitis
Volume 4, Issue 3, Pages 221-256
Publisher
Oxford University Press (OUP)
Online
2010-03-18
DOI
10.1016/j.crohns.2009.12.001
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Review article: use of antitumour necrosis factor therapy in inflammatory bowel disease during pregnancy and conception
- (2010) S. O'DONNELL et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Guidelines for heart transplantation
- (2010) N. de Jonge et al. Netherlands Heart Journal
- Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections
- (2009) S. SCHNEEWEISS et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Tumor Necrosis Factor-α Inhibitor-Induced Psoriasis or Psoriasiform Exanthemata
- (2009) Uwe Wollina et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Adverse Events Associated With Common Therapy Regimens for Moderate-to-Severe Crohn's Disease
- (2009) Josh Marehbian et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Pneumocystis jirovecipneumonia in patients with rheumatoid arthritis treated with infliximab: A retrospective review and case-control study of 21 patients
- (2009) Yukiko Komano et al. ARTHRITIS AND RHEUMATISM
- Dermatological complications and safety of anti-TNF treatments
- (2009) J. F. Kerbleski et al. GUT
- Incidence and clinical significance of immunogenicity to infliximab in Crohnʼs disease
- (2009) Andrea Cassinotti et al. INFLAMMATORY BOWEL DISEASES
- Absence of Infliximab in Infants and Breast Milk From Nursing Mothers Receiving Therapy for Crohnʼs Disease Before and After Delivery
- (2009) Sunanda Kane et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Hepatosplenic T Cell Lymphoma Associated with Infliximab Use in Young Patients Treated for Inflammatory Bowel Disease: Update
- (2009) Ann Corken Mackey et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- A Safety Assessment of Tumor Necrosis Factor Antagonists During Pregnancy: A Review of the Food and Drug Administration Database
- (2009) J. D. CARTER et al. JOURNAL OF RHEUMATOLOGY
- Temporal Relationship Between Antitumor Necrosis Factor-α Antibody Therapy and Recrudescence of Head and Neck Squamous Cell Carcinoma
- (2009) Samuel H. Engel et al. LARYNGOSCOPE
- The safety profile of anti-tumour necrosis factor therapy in inflammatory bowel disease in clinical practice: analysis of 620 patient-years follow-up
- (2008) C. W. LEES et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Infliximab treatment for symptomatic Crohn’s disease strictures
- (2008) A.-L. PELLETIER et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Erythema multiforme with tumour necrosis factor inhibitors: a class effect?
- (2008) T Kain et al. ANNALS OF THE RHEUMATIC DISEASES
- Does tumor necrosis factor α inhibition promote or prevent heart failure in patients with rheumatoid arthritis?
- (2008) Joachim Listing et al. ARTHRITIS AND RHEUMATISM
- Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: A literature review and potential mechanisms of action
- (2008) Angelique N. Collamer et al. ARTHRITIS AND RHEUMATISM
- Autoimmune diseases induced by TNF-targeted therapies
- (2008) Manuel Ramos-Casals et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Review and expert opinion on prevention and treatment of infliximab-related infusion reactions
- (2008) L.L.A. Lecluse et al. BRITISH JOURNAL OF DERMATOLOGY
- Infliximab for Inflammatory Bowel Disease in Denmark 1999–2005: Clinical Outcome and Follow-Up Evaluation of Malignancy and Mortality
- (2008) Sarah Caspersen et al. Clinical Gastroenterology and Hepatology
- Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn's Disease: Meta-Analysis of Placebo-Controlled Trials
- (2008) Laurent Peyrin–Biroulet et al. Clinical Gastroenterology and Hepatology
- Immunogenicity of anti-tumor necrosis factor antibodies—toward improved methods of anti-antibody measurement
- (2008) Lucien Aarden et al. CURRENT OPINION IN IMMUNOLOGY
- Role of Biologics and Other Therapies in Stricturing Crohn’s Disease: What Have We Learnt So Far?
- (2008) D. Sorrentino DIGESTION
- Therapeutic Efficacy of Infliximab on Patients with Short Duration of Crohnʼs Disease: A Japanese Multicenter Survey
- (2008) Takayuki Matsumoto et al. DISEASES OF THE COLON & RECTUM
- Serious Events with Infliximab in Patients with Inflammatory Bowel Disease
- (2008) Hilbert S de Vries et al. DRUG SAFETY
- Withdrawal of Immunosuppression in Crohn's Disease Treated With Scheduled Infliximab Maintenance: A Randomized Trial
- (2008) Gert Van Assche et al. GASTROENTEROLOGY
- Hepatosplenic T cell lymphoma in inflammatory bowel disease
- (2008) M. Shale et al. GUT
- Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study
- (2008) H Fidder et al. GUT
- Tuberculous chemoprophylaxis requirements and safety in inflammatory bowel disease patients prior to anti-TNF therapy
- (2008) Yamile Zabana et al. INFLAMMATORY BOWEL DISEASES
- Autoimmune disease concomitance among inflammatory bowel disease patients in the United States, 2001-2002
- (2008) Russell Cohen et al. INFLAMMATORY BOWEL DISEASES
- Pneumocystis jiroveci (carinii) pneumonia following a second infusion of infliximab in a patient with ulcerative colitis
- (2008) Silvia Estrada et al. INFLAMMATORY BOWEL DISEASES
- Long-term outcome of maintenance infliximab therapy in children with Crohnʼs disease
- (2008) Jeffrey S. Hyams et al. INFLAMMATORY BOWEL DISEASES
- Efficacy of Infliximab in Pediatric Crohnʼs Disease: A Randomized Multicenter Open-Label Trial Comparing Scheduled to On Demand Maintenance Therapy
- (2008) Frank M. Ruemmele et al. INFLAMMATORY BOWEL DISEASES
- Infliximab-induced hepatitis: absence of cross-toxicity with etanercept
- (2008) Gérard Thiéfin et al. JOINT BONE SPINE
- A Double-blind, Placebo-controlled, Randomized Study of Infliximab in Primary Sclerosing Cholangitis
- (2008) Daan W. Hommes et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Induction and exacerbation of psoriasis with TNF-blockade therapy: A review and analysis of 127 cases
- (2008) Justin M. Ko et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Reactivation of hepatitis B in a patient with Crohn’s disease treated using infliximab
- (2008) Keisuke Ojiro et al. JOURNAL OF GASTROENTEROLOGY
- Urticarial vasculitis due do infliximab
- (2008) J Goulão et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- The Effects of HIV on the Sensitivity of a Whole Blood IFN-γ Release Assay in Zambian Adults with Active Tuberculosis
- (2008) Edward Raby et al. PLoS One
- Is infliximab safe to use while breastfeeding?
- (2008) Joel Z Stengel et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Effect of infliximab on small bowel stenoses in patients with Crohn's disease
- (2008) Nadia Pallotta et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon assay
- (2007) G Matulis et al. ANNALS OF THE RHEUMATIC DISEASES
- Focus on adverse events of tumour necrosis factor blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients
- (2007) V Gerloni et al. ANNALS OF THE RHEUMATIC DISEASES
- Severe Listeria meningoencephalitis in an infliximab-treated patient with Crohnʼs disease
- (2007) Ferenc Izbéki et al. INFLAMMATORY BOWEL DISEASES
- Drug-Induced Lupus due to Anti-Tumor Necrosis Factor α Agents
- (2007) Michelle F. Costa et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search